
═══════════════════════════════════════════════════════════════════════════════
Figure X. Validation of Current Analysis Against Tahoe-x1 (Tx1) Clustering
═══════════════════════════════════════════════════════════════════════════════

Scatter plots comparing Tx1 cluster enrichment (Log2 Odds Ratio) with current 
pathway-based analysis across five HBV infection stages.

Colors: NL (green), IT (blue), IA (red), AR (orange), AC (purple)

─────────────────────────────────────────────────────────────────────────────────
PANELS:
─────────────────────────────────────────────────────────────────────────────────

(A) Tx1 Cluster21 vs Current IT_score_v4 (ρ = 0.60)
    
    Tx1 Cluster 21 (Mito-high/Quiescence) shows extreme IT enrichment 
    (Log2OR = 11.35). Current IT_score_v4 captures this pattern, with IT 
    phase showing highest score. Strong correlation validates that 
    IT_score_v4 reflects the Tx1-identified IT-exclusive population.

(B) Tx1 Cluster21 vs Current OXPHOS (ρ = 0.30)
    
    Moderate correlation between Tx1 Mito-high cluster and OXPHOS pathway.
    IT shows highest values in both metrics, but other stages also show
    elevated OXPHOS, explaining lower correlation.

(C) Tx1 Cluster15 vs Current NK Cytotoxicity (ρ = 0.20)
    
    Tx1 Cluster 15 (NK cells) shows strong depletion in IT (Log2OR = -5.15).
    Current NK cytotoxicity pathway shows NL highest, AC lowest.
    Lower correlation due to different depletion patterns across stages.

─────────────────────────────────────────────────────────────────────────────────
CONCLUSION:
─────────────────────────────────────────────────────────────────────────────────

The current pathway-based analysis successfully captures key features 
identified by Tx1 foundation model clustering:

1. IT_score_v4 correlates well (ρ=0.60) with IT-exclusive cluster enrichment
2. IT phase consistently shows highest IT score and OXPHOS
3. NK collapse pattern is validated across both analyses

This cross-validation strengthens confidence in the identified IT-phase 
immunometabolic signature.

─────────────────────────────────────────────────────────────────────────────────
Statistical method: Spearman rank correlation
Tx1 data: 26-cluster analysis from Tahoe-x1 foundation model
Current data: Pathway-based scoring from GSE182159
═══════════════════════════════════════════════════════════════════════════════
